| Journal Articles|
|Effectiveness and safety of vaginal microbicide 1% tenofovir gel for prevention of HIV infection in women|
Abdool Karim Q, Abdool Karim SS, CAPRISA 004 Study Group. 18th International AIDS Conference, Vienna, Austria, July 20, 2010. Includes commentary from the UCSF Institute for Global
|Efficacy of Carraguard for prevention of HIV infection in women in South Africa: a randomized, double-blind, placebo-controlled trial|
Skoler-Karpoff S, Ramjee G, Ahmed K, et al. Lancet 2008;372:1977-87. Includes commentary from the UCSF Institute for Global
|Efficacy of Carraguard for prevention of HIV infection in women in South Africa: a randomised, double-blind, placebo-controlled trial|
Skoler-Karpoff S, Ramjee G, Ahmed K, et al. Lancet. 2008 Dec 6;372(9654):1977-87.
|Lack of effectiveness of cellulose sulfate gel for the prevention of vaginal HIV transmission|
Van Damme L, Govinden R, Mirembe, et al. N Engl J Med. 2008;359:463-72. Includes commentary from the UCSF Institute for Global
|SAVVY vaginal gel (C31G) for prevention of HIV infection: a randomized controlled trial in Nigeria|
Feldblum PJ, Adeiga A, Bakare R, Wevill S, Lendvay A, Obadaki F, et al. PLoS ONE. 2008 Jan; 3(1):e1474. Includes commentary from the UCSF Institute for Global
|Randomised controlled trial of alternative male and female condom promotion strategies targeting sex workers in Madagascar|
Hoke TH, Feldblum PJ, Damme KV, Nasution MD, Grey TW, Wong EL et al. Sex Transm Infect. 2007 Oct;83(6):448-53. Includes commentary from the UCSF Institute for Global
|A Review of Female-Condom Effectiveness: Patterns of Use and Impact on Protected Sex Acts and STI Incidence|
Vijayakumar G, Mabude Z, Smit J, Beksinska M, Lurie M. Int J STD AIDS. 2006 Oct;17(10):652-9. Includes commentary from the UCSF Institute for Global Health.
|Country-wide distribution of the nitrile female condom (FC2) in Brazil and South Africa: A cost-effectiveness analysis|
Dowdy DW, Sweat MD, Holtgrave DR. AIDS. 2006 Oct 24;20(16):2091-8. Includes commentary from the UCSF Institute for Global Health.
|A prospective study assessing the effects of introducing the female condom in a sex worker population in Mombasa, Kenya|
Thomsen SC, Ombidi W, Toroitich-Ruto C, Wong EL, Tucker HO, Homan R, Kingola N, Luchters S. Sex Transm Infect. 2006 Oct;82(5):397-402. Includes commentary from the UCSF Institute for Global Health.
|Safety and tolerability of tenofovir vaginal gel in abstinent and sexually active HIV-infected and uninfected women|
Mayer KH, Maslankowski LA, Gai F, El-Sadr WM, Justman J, Kwiecien A, Masse B, Eshleman SH, Hendrix C, Morrow K, Rooney JF, Soto-Torres L; the HPTN 050 Protocol Team. AIDS. 2006 Feb 28;20(4):543-551.
|The development of vaginal microbicides for the prevention of HIV transmission|
Weber J, Desai K, Darbyshire J. PLoS Med. 2005 May;2(5):e142.
| Guidelines and Best Practices|
| Policy Reports, Papers, and Briefs|
|Less Silence, More Silence: Advocacy to Make Rectal Microbicides A Reality.|
International Rectal Microbicide Advocates, February 2008. [PDF, 2.05 MB]
|Rectal Microbicides: Investments and Advocacy.|
International Rectal Microbicide Working Group, April 2006. [PDF, 772.59 KB]
|Condoms, Contraceptives and Nonoxynol-9: Complex Issues Obscured by Ideology|
Heather Boonstra. The Alan Guttmacher Institute, May 2005. [PDF, 322K]
|Will a Pill a Day Prevent HIV? Anticipating the Results of the Tenofovir "PREP" Trials|
AIDS Vaccine Advocacy Coalition, March 2005. [PDF, 640K]
|Preparing to Deliver: Introduction of Microbicides|
Lilani Kumaranayake, Fern Terris-Prestholt, Charlotte Watts. Department of Public Health and Policy, London School of Hygiene and Tropical Medicine, July 2004. [PDF, 120K]
|Paving the Path: Preparing for Microbicide Introduction--A Report of a Study in South Africa|
EngenderHealth, International Partnership for Microbicides, University of Cape Town, Population Council, 2004. [PDF, 459K]
|The Female Condom: Women Control STI Protection|
Heidi Brown. Population Reference Bureau, March 2003.
|Microbicides: What They Are--Why We Need Them|
Arin Farrington. Health and Sexuality, February 25, 2003.
|The Female Condom: Dynamics of Use in Urban Zimbabwe |
Deanna Kerrigan, Steve Mobley, Naomi Rutenberg, Andrew Fisher, Ellen Weiss. Horizons Project, Population Council, October 2000. [PDF, 1.6MB]
| Provider Education and Training|
| Patient and Community Education|
|Alan Guttmacher Institute|
Nonprofit focused on sexual and reproductive health research, policy analysis, and public education. Publishes periodic reports on microbicides.
|Alliance for Microbicide Development|
Consortium of pharmaceutical companies, scientists, and advocacy groups dedicated to the development of topical microbicides for the prevention of sexually transmitted infections, including HIV.
|Global Campaign for Microbicides|
International effort to build support among policymakers, opinion leaders, and the general public for increased private and public sector investment in microbicide products that women and men could use vaginally or rectally to protect themselves and their partners from HIV and other STIs.
|International Rectal Microbicide Advocates|
IRMA is a network numbering over 600 advocates, policymakers and leading scientists from over 45 countries on six continents working to advance a robust rectal microbicide research and development agenda.
|Microbicides Development Programme|
Aims to evaluate potential microbicides in vitro, carry out safety studies in the United Kingdom and Africa, conduct social science research into acceptability and barriers to uptake of products, and complete phase III effectiveness trials.
International nonprofit institution that conducts biomedical, social science, and public health research. Manages family planning and reproductive health projects including work on microbicides.
|Reproductive Health Technologies Project|
Provides educational materials and technical assistance to individuals and organizations advocating for microbicides.
U.S. National Institute of Allergy and Infectious Diseases, outlining past research, ongoing and future research, and links to other resources.
|Women's Global Health Imperative|
A global research center based at Research Triangle Institute that provides scientific leadership to improve the ability of women and girls to protect themselves from HIV infection including microbicides.
|Center for Health and Gender Equity (CHANGE)|
Focuses on gender, rights, and health vis-à-vis population policy, contraceptive delivery, STIs and HIV, and gender violence. Advocates for expanded access to female and male condoms. The site contains Analyses of the U.S. AIDS Strategy and Resources on Gender and HIV/AIDS
|The Cervical Barrier Advancement Society|
Aims to raise the profile of cervical barrier methods both for preventing pregnancy and potentially HIV and other sexually transmitted infections. Web site contains information about cervical barriers, downloadable materials, images of cervical barriers, and research updates.
Exists to facilitate the rapid development of safe, acceptable, affordable products and methods that provide contraception and/or prevent the sexual transmission of HIV/AIDS and other infections.
|Female Health Company|
Manufacturer of the female condom. Site includes instructions on use and information on the company's partnership with UNAIDS. Periodically issues an electronic newsletter.